M. Vali

发表

Evaluation of different calibrated spherical polyvinyl alcohol microspheres in transcatheter arterial chemoembolization: VX2 tumor model in rabbit liver.

J. Geschwind, Kwang-hun Lee, E. Liapi, 2008, Journal of vascular and interventional radiology : JVIR.

Targeting of VX2 Rabbit Liver Tumor by Selective Delivery of 3-Bromopyruvate: A Biodistribution and Survival Study

R. Wahl, J. Engles, E. Liapi, 2008, Journal of Pharmacology and Experimental Therapeutics.

High-Resolution Ultrasound in Research of Mouse Orthotopic Glioma and Ultrasound-Guided Cell Implant

V. P. Chacko, J. Geschwind, MingDe Lin, 2011 .

The pyruvic acid analog 3-bromopyruvate interferes with the tetrazolium reagent MTS in the evaluation of cytotoxicity.

J. Geschwind, S. Ganapathy-Kanniappan, S. Ota, 2010, Assay and drug development technologies.

3-Bromopyruvate induces endoplasmic reticulum stress, overcomes autophagy and causes apoptosis in human HCC cell lines.

J. Geschwind, R. Loffroy, S. Ganapathy-Kanniappan, 2010, Anticancer research.

Spontaneous tumor regression in a syngeneic rat model of liver cancer: implications for survival studies.

J. Geschwind, S. Ganapathy-Kanniappan, S. Ota, 2012, Journal of vascular and interventional radiology : JVIR.

3-bromopyruvate: a new targeted antiglycolytic agent and a promise for cancer therapy.

R. Loffroy, S. Ganapathy-Kanniappan, S. Ota, 2010, Current pharmaceutical biotechnology.

Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) is pyruvylated during 3-bromopyruvate mediated cancer cell death.

R. Cole, J. Geschwind, Irina Tchernyshyov, 2009, Anticancer research.

Human hepatocellular carcinoma in a mouse model: assessment of tumor response to percutaneous ablation by using glyceraldehyde-3-phosphate dehydrogenase antagonists.

J. Geschwind, M. Torbenson, K. Carson, 2012, Radiology.

Ductal access for prevention and therapy of mammary tumors.

Zhe Zhang, S. Sukumar, E. Jaffee, 2006, Cancer research.

Very High Frequency of Hypermethylated Genes in Breast Cancer Metastasis to the Bone, Brain, and Lung

Kornelia Polyak, Elizabeth Garrett-Mayer, Pedram Argani, 2004, Clinical Cancer Research.

Assessment of Tumoricidal Efficacy and Response to Treatment with 18F-FDG PET/CT After Intraarterial Infusion with the Antiglycolytic Agent 3-Bromopyruvate in the VX2 Model of Liver Tumor

R. Wahl, E. Liapi, M. Buijs, 2011, The Journal of Nuclear Medicine.

Development of a new orthotopic animal model of metastatic liver cancer in the rabbit VX2 model: effect on metastases after partial hepatectomy, intra-arterial treatment with 3-bromopyruvate and chemoembolization

J. Geschwind, M. Buijs, J. Vossen, 2008, Clinical & Experimental Metastasis.

HOXA5 Regulates Expression of the Progesterone Receptor*

S. Sukumar, K. Zeller, V. Raman, 2000, The Journal of Biological Chemistry.

Clostridium perfringens enterotoxin elicits rapid and specific cytolysis of breast carcinoma cells mediated through tight junction proteins claudin 3 and 4.

Pedram Argani, Saraswati Sukumar, S. Weitzman, 2004, The American journal of pathology.

Specificity of the anti-glycolytic activity of 3-bromopyruvate confirmed by FDG uptake in a rat model of breast cancer

R. Wahl, J. Geschwind, T. Ishimori, 2009, Investigational New Drugs.

Intraarterial therapy with a new potent inhibitor of tumor metabolism (3-bromopyruvate): identification of therapeutic dose and method of injection in an animal model of liver cancer.

C. Georgiades, K. Hong, J. Geschwind, 2007, Journal of vascular and interventional radiology : JVIR.